Efficacy of universal bonding agents as desensitizers: in vitro and in vivo studies

Abstract Background Dentin hypersensitivity (DH) is a highly challenging and persistent dental complaint. This study aimed to evaluate the in vitro durability of the universal dentin bonding agents Single Bond Universal (SBU) and OptiBond Universal compared with a specialized desensitizer, Hybrid Coat (HC), and to assess the desensitizing efficacy of SBU and HC in vivo over a 1-year follow-up period. Methods Dental root samples were prepared and treated with the three agents. After 24 h, 3 months, and 6 months, longitudinal sections of the root samples were examined under scanning electron microscopy, and adhesive layer thicknesses were measured. A split-mouth, blinded, randomized controlled trial was then conducted to compare the efficacy of SBU and HC for DH relief, using the visual analog scale (VAS). Assessments were performed at baseline, immediately post-application, and at 1, 3, 6, 9, and 12 months of follow-up, using standardized cold air stimulus protocols. The difference in VAS scores between pre- and post-application was used to measure efficacy. Results The adhesive layer created by SBU was thinner than that created by HC; however, the HC layer degraded more rapidly. After 6 months of water aging, root surfaces in the HC group were exposed, whereas those in the SBU group remained covered. The in vivo study demonstrated that SBU provided desensitizing efficacy comparable to that of HC over the 12-month period. Conclusions Within the limitations of the present study, it can be concluded that the universal bonding agent SBU is effective and durable when applied as a desensitizer. Its efficacy is comparable to that of a dedicated desensitizing treatment. Trial registration NCT07197437 ( https://www.clinicaltrials.gov ), Date of Registration: 15/09/2025. (Retrospectively registered).

Authors

Institutions

Publication Details

Journal
BMC Oral Health
Published
2026-01-29
DOI
https://doi.org/10.1186/s12903-026-07767-z
Primary Topic
Contact Dermatitis and Allergies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy of universal bonding agents as desensitizers: in vitro and in vivo studies

Rongyu Cao, Xue Cai, Xiaoyan Wang
BMC Oral Health
Contact Dermatitis and Allergies
article

Efficacy of universal bonding agents as desensitizers: in vitro and in vivo studies

Rongyu Cao, Xue Cai, Xiaoyan Wang
article en

Abstract

Abstract Background Dentin hypersensitivity (DH) is a highly challenging and persistent dental complaint. This study aimed to evaluate the in vitro durability of the universal dentin bonding agents Single Bond Universal (SBU) and OptiBond Universal compared with a specialized desensitizer, Hybrid Coat (HC), and to assess the desensitizing efficacy of SBU and HC in vivo over a 1-year follow-up period. Methods Dental root samples were prepared and treated with the three agents. After 24 h, 3 months, and 6 months, longitudinal sections of the root samples were examined under scanning electron microscopy, and adhesive layer thicknesses were measured. A split-mouth, blinded, randomized controlled trial was then conducted to compare the efficacy of SBU and HC for DH relief, using the visual analog scale (VAS). Assessments were performed at baseline, immediately post-application, and at 1, 3, 6, 9, and 12 months of follow-up, using standardized cold air stimulus protocols. The difference in VAS scores between pre- and post-application was used to measure efficacy. Results The adhesive layer created by SBU was thinner than that created by HC; however, the HC layer degraded more rapidly. After 6 months of water aging, root surfaces in the HC group were exposed, whereas those in the SBU group remained covered. The in vivo study demonstrated that SBU provided desensitizing efficacy comparable to that of HC over the 12-month period. Conclusions Within the limitations of the present study, it can be concluded that the universal bonding agent SBU is effective and durable when applied as a desensitizer. Its efficacy is comparable to that of a dedicated desensitizing treatment. Trial registration NCT07197437 ( https://www.clinicaltrials.gov ), Date of Registration: 15/09/2025. (Retrospectively registered).

BMC Oral HealthVol. 26(1)
Shandong University of Aeronautics (CN), National Clinical Research (US)
Openalex Percentile: Top 74%
Contact Dermatitis and Allergies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.